FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W148978712> ?p ?o ?g. }

• W148978712 abstract "To introduce the combination method of radiochemoembolization for the treatment of selected hepatic metastases.Twenty patients with biopsy proven hepatic metastases were selected from those who underwent transarterial radiochemoembolization, a novel combination protocol, between January 2009 and July 2010. Patients had different sources of liver metastasis. The treatment included transarterial administration of three chemotherapeutic drugs (mitomycin, doxorubicin and cisplatin), followed by embolization with large (50-150 μm) radioisotope particles of chromic 32P. Multiphasic computer tomography or computer tomography studies, with and without contrast medium injections, were performed for all patients for a short-term period before and after the treatment sessions. The short-term effectiveness of this procedure was evaluated by modified response evaluation criteria in solid tumors (mRECIST), which also takes necrosis into account. The subjective percentage of necrosis was also assessed. The response evaluation methods were based on the changes in size, number, and the enhancement patterns of the lesions between the pre- and post-treatment imaging studies.Patients had liver metastasis from colorectal carcinomas, breast cancer, lung cancer and carcinoid tumors. The response rate based on the mRECIST criteria was 5% for complete response, 60% for partial response, 10% for stable disease, and 25% for progressive disease. Regarding the subjective necrosis percentage, 5% of patients had complete response, 50% had partial response, 25% had stable disease, and 20% had progressive disease. Based on traditional RECIST criteria, 3 patients (15%) had partial response, 13 patients (65%) had stable disease, and 4 patients (20%) had disease progression. In most patients, colorectal carcinoma was the source of metastasis (13 patients). Based on the mRECIST criteria, 8 out of these 13 patients had partial responses, while one remained stable, and 5 showed progressive disease. We also had 5 cases of breast cancer metastasis which mostly remained stable (4 cases), with only one partial response after the procedure. Six patients had bilobar involvement; three of them received two courses of radiochemoembolization. The follow up imaging study of these patients was performed after the second session. In the studied patients there was no evidence of extrahepatic occurrence, including pulmonary radioactive deposition, which was proven by Bremsstrahlung scintigraphy performed after the treatment sessions. For the short-term follow-ups for the 2 mo after the therapy, no treatment related death was reported. The mostly common side effect was post-embolization syndrome, presented as vomiting, abdominal pain, and fever. Nineteen (95%) patients experienced this syndrome in different severities. Two patient had ascites (with pleural effusion in one patient) not related to hepatic failure. Moreover, no cases of acute liver failure, hepatic infarction, hepatic abscess, biliary necrosis, tumor rupture, surgical cholecystitis, or non-targeted gut embolization were reported. Systemic toxicities such as alopecia, marrow suppression, renal toxicity, or cardiac failure did not occur in our study group.Radiochemoembolization is safe and effective for selected hepatic metastases in a short-term follow-up. Further studies are required to show the long-term effects and possible complications of this approach." @default.
• W148978712 created "2016-06-24" @default.
• W148978712 creator A5005907537 @default.
• W148978712 creator A5007835664 @default.
• W148978712 creator A5042123744 @default.
• W148978712 creator A5064189017 @default.
• W148978712 creator A5071550972 @default.
• W148978712 creator A5091046215 @default.
• W148978712 date "2012-10-07" @default.
• W148978712 modified "2023-09-27" @default.
• W148978712 title "Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol." @default.
• W148978712 cites W1576396203 @default.
• W148978712 cites W1604733377 @default.
• W148978712 cites W1761472634 @default.
• W148978712 cites W1964668192 @default.
• W148978712 cites W1966680707 @default.
• W148978712 cites W1967600115 @default.
• W148978712 cites W1969939592 @default.
• W148978712 cites W1970603602 @default.
• W148978712 cites W1971647170 @default.
• W148978712 cites W1975777455 @default.
• W148978712 cites W1979041068 @default.
• W148978712 cites W1990440729 @default.
• W148978712 cites W1994177577 @default.
• W148978712 cites W1996076964 @default.
• W148978712 cites W1998612775 @default.
• W148978712 cites W2000769678 @default.
• W148978712 cites W2003860294 @default.
• W148978712 cites W2006784936 @default.
• W148978712 cites W2007169264 @default.
• W148978712 cites W2008068147 @default.
• W148978712 cites W2012586628 @default.
• W148978712 cites W2020308025 @default.
• W148978712 cites W2020355167 @default.
• W148978712 cites W2024029636 @default.
• W148978712 cites W2036806360 @default.
• W148978712 cites W2038291224 @default.
• W148978712 cites W2045486161 @default.
• W148978712 cites W2063475020 @default.
• W148978712 cites W2066462742 @default.
• W148978712 cites W2068612483 @default.
• W148978712 cites W2072998178 @default.
• W148978712 cites W2074825621 @default.
• W148978712 cites W2078704811 @default.
• W148978712 cites W2079586464 @default.
• W148978712 cites W2082466657 @default.
• W148978712 cites W2083037331 @default.
• W148978712 cites W2093559465 @default.
• W148978712 cites W2094623779 @default.
• W148978712 cites W2095485396 @default.
• W148978712 cites W2101761640 @default.
• W148978712 cites W2103852206 @default.
• W148978712 cites W2105086115 @default.
• W148978712 cites W2124984104 @default.
• W148978712 cites W2132596602 @default.
• W148978712 cites W2136586973 @default.
• W148978712 cites W2136645588 @default.
• W148978712 cites W2137042709 @default.
• W148978712 cites W2139248078 @default.
• W148978712 cites W2143203583 @default.
• W148978712 cites W2144237107 @default.
• W148978712 cites W2148800246 @default.
• W148978712 cites W2148850534 @default.
• W148978712 cites W2150983705 @default.
• W148978712 cites W2153307137 @default.
• W148978712 cites W2161202606 @default.
• W148978712 cites W2330610503 @default.
• W148978712 cites W2340812016 @default.
• W148978712 cites W2413575926 @default.
• W148978712 cites W2417705446 @default.
• W148978712 cites W2984122992 @default.
• W148978712 cites W2993872190 @default.
• W148978712 doi "https://doi.org/10.3748/wjg.v18.i37.5249" @default.
• W148978712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3468858" @default.
• W148978712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23066320" @default.
• W148978712 hasPublicationYear "2012" @default.
• W148978712 type Work @default.
• W148978712 sameAs 148978712 @default.
• W148978712 citedByCount "4" @default.
• W148978712 countsByYear W1489787122014 @default.
• W148978712 countsByYear W1489787122015 @default.
• W148978712 countsByYear W1489787122016 @default.
• W148978712 crossrefType "journal-article" @default.
• W148978712 hasAuthorship W148978712A5005907537 @default.
• W148978712 hasAuthorship W148978712A5007835664 @default.
• W148978712 hasAuthorship W148978712A5042123744 @default.
• W148978712 hasAuthorship W148978712A5064189017 @default.
• W148978712 hasAuthorship W148978712A5071550972 @default.
• W148978712 hasAuthorship W148978712A5091046215 @default.
• W148978712 hasConcept C121332964 @default.
• W148978712 hasConcept C126322002 @default.
• W148978712 hasConcept C142724271 @default.
• W148978712 hasConcept C143998085 @default.
• W148978712 hasConcept C204787440 @default.
• W148978712 hasConcept C2780385302 @default.
• W148978712 hasConcept C61797465 @default.
• W148978712 hasConcept C62520636 @default.
• W148978712 hasConcept C71924100 @default.
• W148978712 hasConceptScore W148978712C121332964 @default.
• W148978712 hasConceptScore W148978712C126322002 @default.

• next